Euromedical Instruments has been a major player in the field of intraoperative detection for over 20 years.
The current generation, EUROPROBE 3.2 is the 4th since the launch of the first version, more than 20 years ago.
Since 2014, we offer an optional Europrobe DUAL version that allows bimodal detection by gamma and fluorescence. To our knowledge, it is the only system in the world that offers both Gamma detection and fluorescence capabilities with the same probe.
The DUAL system is based on audio tracking and GS localisation for both gamma and fluorescence modes, which means that it does not alter surgical practices.
The new-generation Europrobe offers detection of sentinel lymph node via fluorescence and / or gamma, thanks to the injection of green indocyanine (ICG) and radioisotope.
This unique in the world technique represents small risk for patients. The occurrence of side effects or allergic reactions due to ICG is significantly lower than to the patented blue.
In addition, the ICG, once injected, is completely colorless and will not disturb the surgeon at the surgical site.
The injection of this dye, made a few minutes before the procedure is simple and its diffusion is fast.
The bi-modality saves time by quickly switching from one detection mode to the another by simply pressing a foot-switch. The probe that is introduced into the operative site actually guides the gesture to search the sentinel lymph node electively by limiting the dissection, as for the radioisotope.
Studies consider that the combined injection of indocyanine green and radioisotope detected by a bi-modal probe allows an excellent identification rate (99.8%) as well as a highly developed sensitivity rate.[1]
[1] Sentinel node detection in breast cancer using opto-nuclear probes
99m Sentinel node detection using optonuclear probe (gamma and fluorescence) after green indocyanine and radio-isotope injections
M-A. Poumellec, M. Dejode, A. Figl, J. Darcourt, J. Haudebourg, Y. Sabah, A. Voury, A. Martaens, E. Barranger